Zheng Min, Huang Yi, Fei Wei, Shen Yang, Nie Xiong, Gao Ming-Yu
Department of Stomatology, Affiliated Zhoushan Hospital of Wenzhou Medical University, Zhoushan 316004, China.
Department of Stomatology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu 610072, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):342-349. doi: 10.12182/20230360106.
To study the expression of tyrosine kinase receptor 2 (Tie2) in oral squamous cell carcinoma (OSCC) and its effect on cell proliferation and migration and the epithelial-mesenchymal transition (EMT) process.
Immunohistochemistry (IHC) tests were conducted to examine the expression of Tie2 in OSCC tissues and normal oral mucosa tissues. Western blot was performed to examine the expression of Tie2 in dysplastic oral keratinocyte (DOK) cell line and OSCC cell lines, and the cell line with high Tie2 expression was selected as the experimental cell line. The 2-silenced lentiviral vector was successfully transfected onto the experimental cell line for subsequent experiments. Cell proliferation and cloning abilities were examined with CCK-8 and clone formation assays. Cell migration ability was examined with scratch and Transwell assays. The remodeling ability of cytoskeletal F-actin and the expressions of E-cadherin and N-cadherin were examined with confocal laser scanning microscope. Western blot was performed to examine the expression of EMT-related signature proteins, including E-cadherin, N-cadherin, and vimentin, and the expression of the protein kinase B (AKT) and extracellular signal-regulated kinase (ERK).
IHC results showed that the Tie2-positive rate of the OSCC group (74.5%) was significantly higher than that of the control group (19.4%) ( <0.0001). The expression of Tie2 was higher in HSC-4 and SCC-9 cell lines compared to that in DOK cells. The lentiviral shRNA-162 group showed the best silencing effect, which was used as the experimental group and applied in subsequent experiments. Compared with those of the control group, the proliferation, cloning and migration capacities of the cells of the experimental group were significantly reduced. Furthermore, the green fluorescence intensity of the cytoskeleton F-actin was reduced, the number of filamentous pseudopods at the leading edge of the cells decreased and their length was shortened, and the expression of E-cadherin was significantly increased, while the expression of N-cadherin and vimentin was significantly reduced in the experimental group in comparison with those of the control group. The expression of p-AKT and p-ERK proteins decreased, while AKT and ERK protein expression increased.
Tie2 was highly expressed in most OSCC cells. Silencing Tie2 can inhibit the proliferation, cloning, and migration ability of OSCC cells, inhibit F-actin remodeling, and alter the expression of its EMT-related signature proteins by regulating AKT and ERK signaling pathway, which suggests that Tie2 may be involved in the growth, metastasis and EMT process of OSCC.
研究酪氨酸激酶受体2(Tie2)在口腔鳞状细胞癌(OSCC)中的表达及其对细胞增殖、迁移和上皮-间质转化(EMT)过程的影响。
采用免疫组织化学(IHC)检测Tie2在OSCC组织和正常口腔黏膜组织中的表达。通过蛋白质印迹法检测发育异常的口腔角质形成细胞(DOK)细胞系和OSCC细胞系中Tie2的表达,并选择Tie2高表达的细胞系作为实验细胞系。将2沉默慢病毒载体成功转染至实验细胞系用于后续实验。采用CCK-8和克隆形成实验检测细胞增殖和克隆能力。采用划痕实验和Transwell实验检测细胞迁移能力。用共聚焦激光扫描显微镜检测细胞骨架F-肌动蛋白的重塑能力以及E-钙黏蛋白和N-钙黏蛋白的表达。通过蛋白质印迹法检测EMT相关标志性蛋白(包括E-钙黏蛋白、N-钙黏蛋白和波形蛋白)的表达以及蛋白激酶B(AKT)和细胞外信号调节激酶(ERK)的表达。
IHC结果显示,OSCC组的Tie2阳性率(74.5%)显著高于对照组(19.4%)(<0.0001)。与DOK细胞相比,HSC-4和SCC-9细胞系中Tie2的表达更高。慢病毒shRNA-162组显示出最佳的沉默效果,将其作为实验组用于后续实验。与对照组相比,实验组细胞的增殖、克隆和迁移能力显著降低。此外,实验组细胞骨架F-肌动蛋白的绿色荧光强度降低,细胞前缘丝状伪足数量减少且长度缩短,E-钙黏蛋白的表达显著增加,而N-钙黏蛋白和波形蛋白的表达与对照组相比显著降低。p-AKT和p-ERK蛋白的表达降低,而AKT和ERK蛋白表达增加。
Tie2在大多数OSCC细胞中高表达。沉默Tie2可抑制OSCC细胞的增殖、克隆和迁移能力,抑制F-肌动蛋白重塑,并通过调节AKT和ERK信号通路改变其EMT相关标志性蛋白的表达,这表明Tie2可能参与OSCC的生长、转移和EMT过程。